{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T17:40:04Z","timestamp":1658166004163},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1093\/ckj\/sfw144","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T20:05:54Z","timestamp":1482177954000},"page":"375-380","source":"Crossref","is-referenced-by-count":0,"title":["The impact of renal protection clinics on prescription of and adherence to cardioprotective drug therapy in chronic kidney disease patients"],"prefix":"10.1093","volume":"10","author":[{"given":"Fanny","family":"Lepeytre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9loise","family":"Cardinal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Fradette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobien","family":"Verhave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Dorais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"LeLorier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Pichette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Madore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,18]]},"reference":[{"key":"key\n\t\t\t\t20170609105930_sfw144-B1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1525-139X.2003.16025.x","article-title":"Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis","volume":"16","year":"2003","journal-title":"Semin Dial"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/ajkd.2001.22070","article-title":"Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency","volume":"37","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B3","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1681\/ASN.V1271501","article-title":"Management of patients with chronic renal insufficiency in the northeastern United States","volume":"12","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/ndt\/gfh771","article-title":"Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects","volume":"20","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B5","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B6","first-page":"182"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward","volume":"85","year":"2014","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2753.2008.00965.x","article-title":"Chronic kidney disease: appropriateness of therapeutic management and associated factors in the AVENIR study","volume":"15","year":"2009","journal-title":"J Eval Clin Pract"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00002512-200825100-00008","article-title":"Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study","volume":"25","year":"2008","journal-title":"Drugs Aging"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B10","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.279.18.1458","article-title":"Persistence of use of lipid-lowering medications: a cross-national study","volume":"279","year":"1998","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B11","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1503\/cmaj.080351","article-title":"Guidelines for the management of chronic kidney disease","volume":"179","year":"2008","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B12","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000014349","article-title":"Salt and hypertension in end-stage renal disease","volume":"16","year":"1998","journal-title":"Blood Purif"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B17","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1681\/ASN.2006101081","article-title":"Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease","volume":"18","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJMoa053107","article-title":"Efficacy and safety of benazepril for advanced chronic renal insufficiency","volume":"354","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0272-6386(12)80030-8","article-title":"Lipoprotein metabolism and renal failure","volume":"21","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B20","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B22","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B23","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2012.07.049","article-title":"Effects of fibrates in kidney disease: a systematic review and meta-analysis","volume":"60","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B24","first-page":"1","article-title":"KDIGO clinical practice guidelines for lipid management in patients with chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B25","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.jacc.2008.03.025","article-title":"Managing dyslipidemia in chronic kidney disease","volume":"51","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1185\/03007990903500565","article-title":"Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countries","volume":"26","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B27","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","article-title":"Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients","volume":"120","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170609105930_sfw144-B29","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/00005650-199909000-00002","article-title":"Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy","volume":"37","year":"1999","journal-title":"Med Care"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/10\/3\/375\/17689206\/sfw144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T17:11:54Z","timestamp":1658164314000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article-lookup\/doi\/10.1093\/ckj\/sfw144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,18]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,2,18]]},"published-print":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfw144","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,18]]}}}